drugset / Trial / NCT00218023

Medications for Stopping Cocaine Dependence and Preventing Relapse

NCT00218023

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to identify subpopulations and baseline conditions that are most responsive to treatment for cocaine dependent individuals.

Timeline

Start
2006-03
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbidopa Unknown 100 mg
Subject Levodopa Small molecule 400 mg
Subject Modafinil Small molecule 200 mg
Subject Naltrexone Small molecule 25 mg

Indications